Title |
Inducible nitric oxide synthase activation by interleukin-17
|
---|---|
Published in |
Cytokine & Growth Factor Reviews, February 2004
|
DOI | 10.1016/j.cytogfr.2003.10.003 |
Pubmed ID | |
Authors |
Djordje Miljkovic, Vladimir Trajkovic |
Abstract |
Interleukin-17 (IL-17) is a proinflammatory T cell cytokine presumably involved in physiological responses to infection, but also in immunopathology of autoimmune disorders such as rheumatoid arthritis. The proinflammatory action of IL-17 depends considerably on its ability to trigger the expression of inducible nitric oxide (NO) synthase (iNOS), an enzyme responsible for the generation of cytotoxic and immunoregulatory free radical NO. Here we discuss the role of IL-17 in the cytokine network controlling iNOS expression, and analyze signaling pathways employed by IL-17 for the initiation of iNOS gene transcription. We also propose biological consequences of IL-17-mediated NO release that could be relevant for the mechanisms or therapy of autoimmune and inflammatory disorders. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 3% |
Colombia | 1 | 3% |
Unknown | 36 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 9 | 24% |
Researcher | 8 | 21% |
Student > Ph. D. Student | 6 | 16% |
Professor > Associate Professor | 3 | 8% |
Student > Bachelor | 3 | 8% |
Other | 4 | 11% |
Unknown | 5 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 14 | 37% |
Immunology and Microbiology | 5 | 13% |
Medicine and Dentistry | 4 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
Biochemistry, Genetics and Molecular Biology | 2 | 5% |
Other | 7 | 18% |
Unknown | 4 | 11% |